Literature DB >> 32090038

Treatment modalities in Duane's Retraction Syndrome.

Karim A Gaballah1, Dalal Shawky2.   

Abstract

AIM: To study the different treatment modalities needed in cases of Duane's Retraction Syndrome (DRS).
METHODS: This prospective study undergone in more than four years, in Alexandria, included 238 patients of DRS, including type I, 162 patients (68%), type II 12 patients (5%) and type III 64 patients (27%). Surgery was indicated in 98 (41%) of them, to eliminate abnormal head posture, deviation of the eye in primary position, severe retraction of the globe or cosmetically unacceptable upshoot with attempted adduction.
RESULTS: Type I was the most common and type II was the least. Females were predominant in this study, constituting 125 patients (52.5%), and males 113 patients (47.5%). Left eye was more affected, in 110 patients (46.2%), right eye in 91 patients (38.2%) and bilateral in 37 patients (15.6%). Amblyopia was found in 27 patients (11.3%) and treated in 13 patients under 10 years of age, by patching the normal eye. Ninety-eight patients (41%) were operated, the results were most satisfactory and a nomogram is followed in the surgical plan.
CONCLUSION: The surgical management is needed in less than half of the cases and should be planned for every case individually according to the clinical findings, planned nomogram and modified intraoperatively according to the anatomical findings during surgery. International Journal of Ophthalmology Press.

Entities:  

Keywords:  Duane's Retraction Syndrome; forced duction test; globe retraction; globe upshoot; lateral rectus; medial rectus

Year:  2020        PMID: 32090038      PMCID: PMC7013788          DOI: 10.18240/ijo.2020.02.12

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  14 in total

Review 1.  Duane's syndrome.

Authors:  V O Kowal; C A McKeown
Journal:  Int Ophthalmol Clin       Date:  1992

2.  Lateral rectus resection strabismus surgery in unilateral duane syndrome with esotropia and limited abduction.

Authors:  Stephen P Kraft
Journal:  Binocul Vis Strabismus Q       Date:  2010

3.  Congenital deficiency of abduction, associated with impairment of adduction, retraction movements, contraction of the palpebral fissure and oblique movements of the eye. 1905.

Authors:  A Duane
Journal:  Arch Ophthalmol       Date:  1996-10

4.  Congenital anomalies in Duane's retraction syndrome.

Authors:  D D Pfaffenbach; H E Cross; T P Kearns
Journal:  Arch Ophthalmol       Date:  1972-12

5.  The efficacy of asymmetric bilateral medial rectus muscle recession surgery in unilateral, esotropic, type 1 Duane syndrome.

Authors:  Gad Dotan; Ainat Klein; Noa Ela-Dalman; Shiri Shulman; Chaim Stolovitch
Journal:  J AAPOS       Date:  2012-12       Impact factor: 1.220

6.  Clinical features associated with an I126M alpha2-chimaerin mutation in a family with autosomal-dominant Duane retraction syndrome.

Authors:  Claudia E Murillo-Correa; Veronica Kon-Jara; Elizabeth C Engle; Juan C Zenteno
Journal:  J AAPOS       Date:  2009-06       Impact factor: 1.220

7.  Y-split recession vs isolated recession of the lateral rectus muscle in the treatment of vertical shooting in exotropic Duane retraction syndrome.

Authors:  Mohamed Fathy A Farid
Journal:  Eur J Ophthalmol       Date:  2016-01-19       Impact factor: 2.597

8.  Evaluation of periosteal fixation of lateral rectus and partial VRT for cases of exotropic Duane retraction syndrome.

Authors:  Pradeep Sharma; Ruchi Tomer; Vimla Menon; Rohit Saxena; Anudeepa Sharma
Journal:  Indian J Ophthalmol       Date:  2014-02       Impact factor: 1.848

Review 9.  Management of Duane retraction syndrome: A simplified approach.

Authors:  Nripen Gaur; Pradeep Sharma
Journal:  Indian J Ophthalmol       Date:  2019-01       Impact factor: 1.848

Review 10.  Surgical treatment of Duane retraction syndrome.

Authors:  Mohammad Reza Akbari; Vahideh Manouchehri; Arash Mirmohammadsadeghi
Journal:  J Curr Ophthalmol       Date:  2017-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.